OPTI - Ticker AI Digest

OptiBiotix Health Plc
6.33 | Today 1.28%
Desk Snapshot GO VIP Login
Important AI Risk Notice

Charts, catalyst summaries, AI scores, forecasts and price context are AI-driven and can hallucinate, lag or miss market-changing information.

Not investment advice. Markets can move fast and any trade or allocation decision remains your responsibility.
AI can hallucinate. Summaries, rankings, forecasts and commentary can be wrong, incomplete or misleading.
AI-driven data only. Signals, dates, prices, sentiment and automation outputs may be delayed, estimated or stale.
Always verify externally. Confirm prices, filings, broker notes and trade setup details with independent sources before acting.
Mobile Command Deck
OptiBiotix Health Plc in one cleaner mobile flow.
Tap straight into the module you want. No sideways tab hunt, just a clean route into charts, news, Today’s AI, and the deeper desks.
OPTI Data 2026-06-01 Preview Mode
Core Deck
Deep Dive Modules

Digested News

Today's Catalysts (OPTI) 0
No same-day market news for OPTI on 2026-06-01.
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 1
OPTI 06:01
OptiBiotix Health Plc
Director/PDMR Shareholding
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
OptiBiotix Health plc (AIMOPTI), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitute, announces that the Company has been informed that David Blain, a Director of the Company, made the following <mark style="background-color:yellow">purchase</mark> of ordinary shares in the capital of the Company.
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 1
OPTI 06:01
OptiBiotix Health Plc
Final Results & Notice of AGM
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
OptiBiotix Health PLC, a life sciences company, announced its audited results for the 12 months ended December 31, 2025, highlighting significant growth and strategic advancements. Key points include
**Revenue Growth**Revenues increased by 34% to £1.17 million, with an additional £212,000 in orders carried forward to 2026.
**Gross Profit Improvement**Gross profit rose by 85% to £614,000, with a gross profit margin of 53%, up from 38% in 2024.
**Operating Costs**Remained stable at just under £2.7 million, excluding non-cash share-based payments.
**Cash Position**Cash balance increased to £1.04 million from £739,000 in 2024, with no debt.
**Investments**Holdings in ProBiotix Health Plc (PBX) and SkinBioTherapeutics Plc (SBTX) valued at £6.45 million as of December 31, 2025.
**Product Launches**SlimBiome® launched in Hydroxycut, the No. 1 weight loss supplement brand in the USA, and a distribution agreement signed with a weight management company.
**Market Expansion**Growing presence in Asia with 17 products launched and 74 customer projects in development across six countries.
**Production Optimization**Introduced an enzyme-based production process for SweetBiotix, improving yield, purity, and taste while reducing costs.
**Post-Period Highlights**Received a 24-metric tonne SlimBiome order from Taiwan, over £800,000 in orders in January 2026, and commenced a clinical study on WellBiome.
**Strategic Focus**Shifted focus to high-growth areas, cost reduction, and commercial sustainability, with planned savings of £500,000-£600,000 annually.
**AGM Notice**Annual General Meeting scheduled for June 23, 2026, at 2 pm in London.
The company aims to achieve profitability by focusing on high-growth markets, improving margins, and commercializing second-generation products like SweetBiotix.
Financial Metric20242025Change
Revenue£870k£1.17m+34%
Gross Profit£331k£614k+85%
Gross Profit Margin38%53%+15%
Operating Costs (excl. non-cash share-based payments)£2.6m£2.7m+4%
Cash Balance£739k£1.04m+41%
Holdings in PBX and SBTX (Market Value)£9.23m£6.45m-29%
Debt£0£0No Change
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 0
No items for this category on selected date.
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 0
No items for this category on selected date.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 3
OPTI 06:01
OptiBiotix Health Plc
Director/PDMR Shareholding
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
OptiBiotix Health plc (AIMOPTI), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitute, announces that the Company has been informed that David Blain, a Director of the Company, made the following <mark style="background-color:yellow">purchase</mark> of ordinary shares in the capital of the Company.
OPTI 06:01
OptiBiotix Health Plc
Final Results & Notice of AGM
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
OptiBiotix Health PLC, a life sciences company, announced its audited results for the 12 months ended December 31, 2025, highlighting significant growth and strategic advancements. Key points include
**Revenue Growth**Revenues increased by 34% to £1.17 million, with an additional £212,000 in orders carried forward to 2026.
**Gross Profit Improvement**Gross profit rose by 85% to £614,000, with a gross profit margin of 53%, up from 38% in 2024.
**Operating Costs**Remained stable at just under £2.7 million, excluding non-cash share-based payments.
**Cash Position**Cash balance increased to £1.04 million from £739,000 in 2024, with no debt.
**Investments**Holdings in ProBiotix Health Plc (PBX) and SkinBioTherapeutics Plc (SBTX) valued at £6.45 million as of December 31, 2025.
**Product Launches**SlimBiome® launched in Hydroxycut, the No. 1 weight loss supplement brand in the USA, and a distribution agreement signed with a weight management company.
**Market Expansion**Growing presence in Asia with 17 products launched and 74 customer projects in development across six countries.
**Production Optimization**Introduced an enzyme-based production process for SweetBiotix, improving yield, purity, and taste while reducing costs.
**Post-Period Highlights**Received a 24-metric tonne SlimBiome order from Taiwan, over £800,000 in orders in January 2026, and commenced a clinical study on WellBiome.
**Strategic Focus**Shifted focus to high-growth areas, cost reduction, and commercial sustainability, with planned savings of £500,000-£600,000 annually.
**AGM Notice**Annual General Meeting scheduled for June 23, 2026, at 2 pm in London.
The company aims to achieve profitability by focusing on high-growth markets, improving margins, and commercializing second-generation products like SweetBiotix.
Financial Metric20242025Change
Revenue£870k£1.17m+34%
Gross Profit£331k£614k+85%
Gross Profit Margin38%53%+15%
Operating Costs (excl. non-cash share-based payments)£2.6m£2.7m+4%
Cash Balance£739k£1.04m+41%
Holdings in PBX and SBTX (Market Value)£9.23m£6.45m-29%
Debt£0£0No Change
OPTI 06:01
OptiBiotix Health Plc
SweetBiotix® Sampling

Today's AI

Today's AI Starts With News

Today’s AI opens with the latest catalyst tape for OPTI.

No same-day headline has printed on 2026-06-01 yet, but the latest digestion still leads Today’s AI before the findings and blend stack below. Financial Forecastist remains wired into the blend.
Standby Tape Data 2026-06-01 Blend Lower Down
Read the alert tape first, then open Today’s AI findings. Use AI Expand on any card to open the AI explanation, results tables and financial forecast rows instantly.
0 Today
Front Of Desk
The live alert stack is quiet right now, but the latest digestion is still parked at the top before the findings and blend stack below.
06:01 Latest Tape SweetBiotix® Sampling
Single-Ticker Today's AI
OPTI signal theatre built from scored market catalysts, automated AI forecasts, financial forecasting and live trigger logic.

This is the ticker-specific Today’s AI desk for OptiBiotix Health Plc. It compresses the live catalyst tape, bullish and bearish scoring, AI price forecasts, financial forecasting and trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI + Financial Blend Buy / Sell Trigger Engine Today's AI Findings
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full OPTI Today’s AI cockpit.

Subscription turns this tab into a live signal desk with today’s news findings at the top, AI plus financial blend comparisons at the bottom, buy and sell trigger logic, and the full findings ledger behind every scored row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific Today’s AI stack, sentiment gauges, AI blend stage, and the full findings ledger for OPTI on 2026-06-01.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
6.5M
Enterprise Value
15.2M
Public Float
89.8
Broker Target
-
Shares Out
103.3M
Long Interest
85
Short Interest
15
Exchange
LSE
Currency Code
GBX
ISIN
GB00BP0RTP38
Market
LSE - AIM
Sector
Pharmaceuticals and Biotechnology
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

News And Alerts First

The alert tape opens the door for OPTI, and Financial Forecastist sits just below.

No same-day alert has printed on 2026-06-01 yet, but the latest digestion is pinned here first so the forecastist view below still opens with context instead of raw numbers.
Standby Alerts Data 2026-06-01 Forecastist Below
Read the alert tape first, then move into Financial Forecastist below. Use AI Expand on any catalyst card to open the AI explanation and results tables without losing the ticker context.
0 Alerts
Front Of Desk
The live alert stack is quiet right now, but the latest digestion is still parked at the top before the forecastist read below.
06:01 Latest Alert SweetBiotix® Sampling
Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
-
Ex Divi
2009-01-01
Earnings Date
2025-09-25
Net Debt
-1.0M
Cash
1.0M
EPS
-0.04
Net Income
-3.9M
Revenue
1.2M
Enterprise Value
15.2M
Trailing PE
-
Forward PE
-
Price Sales TTM
5.6093
Price Book MRQ
1.0277
EV Revenue
4.6477
EV EBITDA
-1.3945
Financial Forecastist

Improving financial engine

Revenue is accelerating +107.8% against the prior comparable period. Net margin is compressing by 379.6 pts. Net debt is building +63.3%.

Revenue +107.8% Net Income +1305.7% FCF +48.9% Current Ratio 4.27x Forward Rev 0
Improving
Quarter Revenue
609.0K
+107.8%
vs prior comparable quarter
Net Margin
-445.5%
-379.6 pts
profitability pulse
Free Cash Flow
-895.0K
+48.9%
cash conversion
Net Debt / EBITDA
0.6x
+63.3%
lower is cleaner
Revenue Engine

Latest quarter printed 609.0K with the top line pushing higher against the last comparable period.

Profit Stack

Net income landed at -2.7M and the margin profile is tightening. That usually tells us whether operating leverage is finally kicking in.

Balance-Sheet Pressure

Cash sits near 1.0M while net debt is -1.0M. The leverage stack is moving the wrong way.

Quarterly Revenue Runway

Actual revenue bars, consensus revenue where available, plus the terminal model path.

Profit And Cash Conversion

Net income and free cash flow moving together is usually what separates genuine improvement from noise.

Balance-Sheet Pressure

Cash, net debt and liquidity tell us whether the business is strengthening or just surviving.

Annual Power Curve

Longer-cycle revenue and net income help frame whether the company is compounding or rolling over.
Q1 2022
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
Q2 2022
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
Q3 2022
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
Q1 2023
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
FY 2023
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
FY 2025
Consensus
0
Revenue Path
-
EPS / Earnings
Growth cue -

Quarterly Statement Tape

Last 6 Quarters
Period Revenue Net Income FCF Net Debt
Q4 2025 609.0K -2.7M - -1.0M
Q2 2025 557.0K -1.2M -895.0K -1.3M
Q4 2024 594.0K 986.0K -1.0M -739.0K
Q2 2024 276.0K -2.8M -745.0K -1.3M
Q4 2023 293.0K -193.0K -926.0K -635.0K
Q2 2023 351.0K -1.8M -601.0K -893.0K

Annual Financial Power

Last 5 Years
Period Revenue Net Income EBITDA FCF
FY 2025 1.2M -3.9M -3.1M -
FY 2024 870.0K -1.8M -2.1M -1.8M
FY 2023 644.0K -2.0M -1.8M -1.5M
FY 2022 457.0K 2.6M 2.7M -1.3M
FY 2021 2.2M 6.3M 6.5M -1.8M

Structure DNA

Market Structure DNA

Balanced Structure profile with trend broken

Price is 4.2% through the 52-week range, -8.5% vs 50DMA and -35.2% vs 200DMA. 19.3% of the register is locked by institutions and insiders, leaving 80.7% free float. Capital rhythm reads no cadence with forward yield near 0.0% and payout around 0.0%.

Trend broken Balanced register Moderate income rhythm As Of 2026-04-19
Balanced Structure
Structure Score
33.1 / 100
Balanced Structure
Trend Stack
-8.5% / -35.2%
vs 50DMA / 200DMA
52W Position
4.2%
auction position inside the yearly range
Ownership Lock
19.3%
7.7% institutions | 11.5% insiders
Pressure Pocket
80.7% free float
Vendor short-float fields were not supplied
Capital Rhythm
No cadence
Yield 0.0% | payout 0.0%
Trend Runway

Implied spot is 5.35 with the stock -8.5% vs 50DMA and -35.2% vs 200DMA. The tape is sitting 4.2% through the 52-week range, which frames the regime as trend broken.

Ownership Register

Institutions hold about 7.7% and insiders about 11.5%, locking roughly 19.3% of the register and leaving 80.7% in free float. That reads as balanced register.

Pressure Pocket

The API did not return a usable short-float field for this ticker, so the pressure score leans more on float lock and crowding than a full short ledger.

Capital Rhythm

Dividend cadence reads no cadence with - event(s) in the last full year, a five-year average of -, and stability score 0.0/100. Forward yield sits near 0.0% while payout is around 0.0%.

Structure Score

One-glance gauge for the current market-structure regime.

Pillar Radar

Trend, ownership, pressure, and capital rhythm mapped on one wheel.

Position And Float Balance

Shows whether the stock is extended, tightly held, or carrying capital-return support.

Dividend Cadence Tape

Historical dividend-event counts help reveal how dependable the income rhythm has been.

Dividend Cadence Ledger

No cadence
Year Dividend Count Context
Dividend history has not been normalized yet.

Structure Facts

Live Snapshot
Implied Spot
5.35
derived from market cap / shares
52W High
21.00
upper auction edge
52W Low
4.66
lower auction edge
Beta
1.86
volatility character
Shares Out
103.3M
fully diluted count
Shares Float
92.8M
tradable register
Shares Short
0
borrowed stock
Short Ratio
0.0x
days-to-cover style read
Ex-Dividend
-
next ex-date not supplied
Dividend Pay
-
payment date not supplied
Last Split
1:200
2014-08-05

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
103300304
Public Hands
89.84
Institutions
-
Institutions As Of
-
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
2
Sale Director Dealing
0
Purchase TR1
0
Sale TR1
0
Broker Coverage Rows
0
Institution Holders Tracked
0
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

News And Alerts First

Start with the latest alert tape for OPTI, then drop into AI Charts below.

No same-day headline has printed on 2026-06-01 yet, but the latest digestion is parked at the top before the chart workspace below so users can frame price, AI targets and structure from the latest tape.
Standby Tape Data 2026-06-01 AI Charts Below
Read the alert tape first, then move into AI Charts below. Use AI Expand on any catalyst card to open the AI explanation and results tables instantly.
0 Today
Catalyst Pulse
The live alert stack is quiet right now, but the latest digestion is still parked at the top before the chart read below.
06:01 Latest Tape SweetBiotix® Sampling
AI Charts Studio
OPTI Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2026-06-01 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
Desk Snapshot Member Login
Indicators0
Technicals0
AI Forecast -15.96%
RSI Gauge
Price Change
AI Forecast